These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 35155438)
61. An immune-related pseudogene signature to improve prognosis prediction of endometrial carcinoma patients. Tang S; Zhuge Y Biomed Eng Online; 2021 Jun; 20(1):64. PubMed ID: 34193185 [TBL] [Abstract][Full Text] [Related]
62. Identification, Verification and Pathway Enrichment Analysis of Prognosis-Related Immune Genes in Patients With Hepatocellular Carcinoma. Zhu Z; Song M; Li W; Li M; Chen S; Chen B Front Oncol; 2021; 11():695001. PubMed ID: 34616672 [TBL] [Abstract][Full Text] [Related]
63. Integrated analysis on the N6-methyladenosine-related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma. Qiu Y; Wang X; Fan Z; Zhan S; Jiang X; Huang J Immun Inflamm Dis; 2021 Dec; 9(4):1596-1612. PubMed ID: 34432955 [TBL] [Abstract][Full Text] [Related]
64. Value of 18fluorodeoxyglucose-positron-emission tomography in amyotrophic lateral sclerosis: a prospective study. Van Laere K; Vanhee A; Verschueren J; De Coster L; Driesen A; Dupont P; Robberecht W; Van Damme P JAMA Neurol; 2014 May; 71(5):553-61. PubMed ID: 24615479 [TBL] [Abstract][Full Text] [Related]
65. Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis. Huang C; Zhang C; Sheng J; Wang D; Zhao Y; Qian L; Xie L; Meng Z Front Genet; 2021; 12():717319. PubMed ID: 34899826 [No Abstract] [Full Text] [Related]
67. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer. Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791 [No Abstract] [Full Text] [Related]
68. Identification of immune-related gene signature predicting survival in the tumor microenvironment of lung adenocarcinoma. Zhao M; Li M; Chen Z; Bian Y; Zheng Y; Hu Z; Liang J; Huang Y; Yin J; Zhan C; Feng M; Wang Q Immunogenetics; 2020 Dec; 72(9-10):455-465. PubMed ID: 33188484 [TBL] [Abstract][Full Text] [Related]
69. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer. Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319 [TBL] [Abstract][Full Text] [Related]
70. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma. Song D; Tian J; Han X; Li X Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165 [TBL] [Abstract][Full Text] [Related]
71. Comprehensive Analysis of the Immune and Prognostic Implication of COL6A6 in Lung Adenocarcinoma. Ma Y; Qiu M; Guo H; Chen H; Li J; Li X; Yang F Front Oncol; 2021; 11():633420. PubMed ID: 33747955 [TBL] [Abstract][Full Text] [Related]
72. Immune Infiltration-Related Signature Predicts Risk Stratification and Immunotherapy Efficacy in Grade II and III Gliomas. Luo C; Liu Z; Ye W; Liu F Front Cell Dev Biol; 2021; 9():756005. PubMed ID: 34805164 [No Abstract] [Full Text] [Related]
73. Glycolysis Define Two Prognostic Subgroups of Lung Adenocarcinoma With Different Mutation Characteristics and Immune Infiltration Signatures. Huo C; Zhang MY; Li R; Liu TT; Li JP; Qu YQ Front Cell Dev Biol; 2021; 9():645482. PubMed ID: 34368114 [TBL] [Abstract][Full Text] [Related]
74. Metabolic Alteration and Amyotrophic Lateral Sclerosis Outcome: A Systematic Review. Brito MD; da Silva GFG; Tilieri EM; Araujo BG; Calió ML; Rosenstock TR Front Neurol; 2019; 10():1205. PubMed ID: 31824397 [No Abstract] [Full Text] [Related]
75. Retinoic Acid Metabolism-Related Enzyme Signature Identified Prognostic and Immune Characteristics in Sarcoma. Xu H; Hu J; Song Y; Chen H; Xu Y; Deng C; Wu H; Song G; Lu J; Tang Q; Xia L; Wang J; Zhu X Front Cell Dev Biol; 2021; 9():780951. PubMed ID: 35186946 [TBL] [Abstract][Full Text] [Related]
76. A DUAL MTOR/NAD+ ACTING GEROTHERAPY. Li J; Kumar S; Miachin K; Bean NL; Halawi O; Lee S; Park J; Pierre TH; Hor JH; Ng SY; Wallace KJ; Rindtorff N; Miller TM; Niehoff ML; Farr SA; Kletzien RF; Colca J; Tanis SP; Chen Y; Griffett K; McCommis KS; Finck BN; Peterson TR bioRxiv; 2023 Jan; ():. PubMed ID: 36711589 [TBL] [Abstract][Full Text] [Related]
77. Integrating RNA-seq and scRNA-seq to explore the biological significance of NAD + metabolism-related genes in the initial diagnosis and relapse of childhood B-cell acute lymphoblastic leukemia. Lin C; Xu JQ; Zhong GC; Chen H; Xue HM; Yang M; Chen C Front Immunol; 2022; 13():1043111. PubMed ID: 36439178 [TBL] [Abstract][Full Text] [Related]
78. A conjoint analysis of bulk RNA-seq and single-nucleus RNA-seq for revealing the role of ferroptosis and iron metabolism in ALS. Fu X; He Y; Xie Y; Lu Z Front Neurosci; 2023; 17():1113216. PubMed ID: 36937665 [TBL] [Abstract][Full Text] [Related]
79. A prognostic NAD+ metabolism-related gene signature for predicting response to immune checkpoint inhibitor in glioma. Jiang C; Zhou Y; Yan L; Zheng J; Wang X; Li J; Jiang X Front Oncol; 2023; 13():1051641. PubMed ID: 36845744 [TBL] [Abstract][Full Text] [Related]
80. Comprehensive analysis of autoimmune-related genes in amyotrophic lateral sclerosis from the perspective of 3P medicine. Li S; Zhang Q; Li J; Weng L EPMA J; 2022 Dec; 13(4):699-723. PubMed ID: 36505891 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]